GB1529871A - E coli enterotoxin purification - Google Patents
E coli enterotoxin purificationInfo
- Publication number
- GB1529871A GB1529871A GB44308/75A GB4430875A GB1529871A GB 1529871 A GB1529871 A GB 1529871A GB 44308/75 A GB44308/75 A GB 44308/75A GB 4430875 A GB4430875 A GB 4430875A GB 1529871 A GB1529871 A GB 1529871A
- Authority
- GB
- United Kingdom
- Prior art keywords
- coli
- purification
- coli enterotoxin
- enterotoxin
- vaccines
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0258—Escherichia
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
1529871 E. Coli enterotoxin vaccines SANDOZ Ltd 28 Oct 1975 [1 Nov 1974 11 Dec 1974 (2) 12 May 1975] 44308/75 Heading A5B E. Coli enterotoxin of at least 99% purity is obtained from a crude or pre-purified cell free culture filtrate of a fermenter culture of an enteropathogenic E. Coli strain by subjecting the culture filtrate to isotachophoretic or affinity chromatographic separations. The purified and heat-labile (L.T.) E. Coli enterotoxins may be formulated as vaccines.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1467174A CH612994A5 (en) | 1974-11-01 | 1974-11-01 | Process for the preparation of coli enterotoxin |
| CH1645874 | 1974-12-11 | ||
| CH1645974 | 1974-12-11 | ||
| CH604075A CH615196A5 (en) | 1975-05-12 | 1975-05-12 | Purification process for coli enterotoxin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1529871A true GB1529871A (en) | 1978-10-25 |
Family
ID=27428963
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB44308/75A Expired GB1529871A (en) | 1974-11-01 | 1975-10-28 | E coli enterotoxin purification |
Country Status (16)
| Country | Link |
|---|---|
| JP (1) | JPS5170810A (en) |
| AU (1) | AU511934B2 (en) |
| CA (1) | CA1053152A (en) |
| DD (1) | DD124879A5 (en) |
| DE (1) | DE2547224A1 (en) |
| DK (2) | DK478575A (en) |
| ES (1) | ES442242A1 (en) |
| FI (2) | FI752964A (en) |
| FR (1) | FR2289206A1 (en) |
| GB (1) | GB1529871A (en) |
| IE (1) | IE43702B1 (en) |
| IL (1) | IL48384A (en) |
| NL (1) | NL7512590A (en) |
| NO (1) | NO753578L (en) |
| NZ (1) | NZ179108A (en) |
| SE (1) | SE8100404L (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0170496A2 (en) * | 1984-07-30 | 1986-02-05 | The Board Of Trustees Of The Leland Stanford Junior University | Vaccine against urinary tract infection |
| WO1986006635A1 (en) * | 1985-05-15 | 1986-11-20 | Biotechnology Australia Pty. Ltd. | Oral vaccines |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA738364B (en) * | 1972-12-04 | 1974-09-25 | Rit Rech Ind Therapeut | Piglet colibacillosis vaccines and process for their preparation |
-
1975
- 1975-10-22 DE DE19752547224 patent/DE2547224A1/en not_active Ceased
- 1975-10-23 DK DK478575A patent/DK478575A/en unknown
- 1975-10-23 FI FI752964A patent/FI752964A/fi not_active Application Discontinuation
- 1975-10-24 NO NO753578A patent/NO753578L/no unknown
- 1975-10-28 NL NL7512590A patent/NL7512590A/en not_active Application Discontinuation
- 1975-10-28 GB GB44308/75A patent/GB1529871A/en not_active Expired
- 1975-10-29 IE IE2352/75A patent/IE43702B1/en unknown
- 1975-10-30 NZ NZ179108A patent/NZ179108A/en unknown
- 1975-10-30 IL IL48384A patent/IL48384A/en unknown
- 1975-10-30 CA CA238,673A patent/CA1053152A/en not_active Expired
- 1975-10-30 DD DD189144A patent/DD124879A5/xx unknown
- 1975-10-30 ES ES442242A patent/ES442242A1/en not_active Expired
- 1975-10-31 FR FR7533471A patent/FR2289206A1/en active Granted
- 1975-10-31 JP JP50132085A patent/JPS5170810A/ja active Pending
- 1975-11-03 AU AU86282/75A patent/AU511934B2/en not_active Expired
-
1978
- 1978-06-20 DK DK278478A patent/DK278478A/en unknown
- 1978-09-14 FI FI782827A patent/FI782827A/en not_active Application Discontinuation
-
1981
- 1981-01-23 SE SE8100404A patent/SE8100404L/en unknown
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0170496A2 (en) * | 1984-07-30 | 1986-02-05 | The Board Of Trustees Of The Leland Stanford Junior University | Vaccine against urinary tract infection |
| EP0170496A3 (en) * | 1984-07-30 | 1987-11-25 | The Board Of Trustees Of The Leland Stanford Junior University | Vaccine against urinary tract infection |
| WO1986006635A1 (en) * | 1985-05-15 | 1986-11-20 | Biotechnology Australia Pty. Ltd. | Oral vaccines |
Also Published As
| Publication number | Publication date |
|---|---|
| FI782827A (en) | 1978-09-14 |
| IE43702L (en) | 1976-05-01 |
| AU511934B2 (en) | 1980-09-11 |
| IL48384A0 (en) | 1976-03-31 |
| ES442242A1 (en) | 1977-08-01 |
| DE2547224A1 (en) | 1976-05-13 |
| IE43702B1 (en) | 1981-05-06 |
| JPS5170810A (en) | 1976-06-18 |
| AU8628275A (en) | 1977-05-12 |
| IL48384A (en) | 1979-05-31 |
| DK278478A (en) | 1978-06-20 |
| NZ179108A (en) | 1978-07-28 |
| FI752964A (en) | 1976-05-02 |
| DD124879A5 (en) | 1977-03-16 |
| DK478575A (en) | 1976-05-02 |
| NL7512590A (en) | 1976-05-04 |
| SE8100404L (en) | 1981-01-23 |
| FR2289206B1 (en) | 1978-11-10 |
| FR2289206A1 (en) | 1976-05-28 |
| NO753578L (en) | 1976-05-04 |
| CA1053152A (en) | 1979-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO854334L (en) | TRANSFORMATION OF YEAR SPECIES OF THE PICHIA genus. | |
| EP0230021A3 (en) | Continuous process for the production of organic acids by means of fermentation | |
| JPS5645483A (en) | C-15003phm and its preparation | |
| SE8602870L (en) | SET AND DEVICE FOR CLEANING NITROGEN | |
| GB1534812A (en) | Method for the purification of interferon | |
| KR960700346A (en) | A PROCESS FOR PRODUCING IMMUNOSUPPRESSIVES AND A NOVEL MICROBIAL SPECIES TO BE EMPLOYED THEREIN | |
| SE9201544D0 (en) | MAKE SUBSTANTIAL GYCOSYL TRANSFER PHASES | |
| ES8602135A1 (en) | BBM-2478 Antibiotic complex | |
| KR860000236A (en) | Process for producing ester of triterphenyl of organic acid | |
| GB1529871A (en) | E coli enterotoxin purification | |
| AU5894886A (en) | High performance liquid chromatography mobile phase | |
| KR850001284A (en) | Antibiotics produced by KIBDELOSPORANGIUM ARIDUM SHEARER GEN.NOV., GEN.NOV., SP.NOV.ATCC 39323 | |
| GB1299136A (en) | Improvements in or relating to prostaglandins and the preparation thereof | |
| GB1252287A (en) | ||
| GB1516219A (en) | Microscope | |
| ES472790A1 (en) | Antibiotic auromomycin, and process for production thereof | |
| KR860006543A (en) | Method for preparing interferon-γ | |
| GB1402349A (en) | Purification process for gn-rh | |
| ES449582A1 (en) | Improvement concerning about organic compound | |
| GB1452457A (en) | Microbiological production of biologically active 8,8-bi-1h- naphthol-2,3-c-pyrans | |
| GB1226665A (en) | ||
| ES8604022A1 (en) | Process for the isolation and purification of alpha-interferons. | |
| AU513367B2 (en) | Method of supplying extra oxygen to yeast cultures | |
| JPS5352682A (en) | Purification of l-methionase | |
| JPS56124387A (en) | Production of terpene acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PCNP | Patent ceased through non-payment of renewal fee |